Merus

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Merus and other ETFs, options, and stocks.

About MRUS

Merus NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of bispecific antibody therapeutics. Its pipeline includes Biclonics for solid and hematological tumors. 

CEO
Jan G. J. van de Winkel
CEOJan G. J. van de Winkel
Employees
260
Employees260
Headquarters
Utrecht, Utrecht
HeadquartersUtrecht, Utrecht
Founded
2003
Founded2003
Employees
260
Employees260

MRUS Key Statistics

Market cap
7.35B
Market cap7.35B
Price-Earnings ratio
-18.16
Price-Earnings ratio-18.16
Dividend yield
Dividend yield
Average volume
1.13M
Average volume1.13M
High today
$96.96
High today$96.96
Low today
$96.91
Low today$96.91
Open price
$96.92
Open price$96.92
Volume
193.79K
Volume193.79K
52 Week high
$97.14
52 Week high$97.14
52 Week low
$33.19
52 Week low$33.19

Stock Snapshot

Merus(MRUS) stock is priced at $96.91, giving the company a market capitalization of 7.35B. It carries a P/E multiple of -18.16.

As of 2025-12-24, Merus(MRUS) stock has fluctuated between $96.91 and $96.96. The current price stands at $96.91, placing the stock 0.0% above today's low and -0.1% off the high.

Merus(MRUS) shares are trading with a volume of 193.79K, against a daily average of 1.13M.

During the past year, Merus(MRUS) stock moved between $33.19 at its lowest and $97.14 at its peak.

During the past year, Merus(MRUS) stock moved between $33.19 at its lowest and $97.14 at its peak.

MRUS News

TipRanks 2d
Major Biotech Player Quietly Ramps Up Its Stake in Merus

New insider activity at Merus ( (MRUS) ) has taken place on December 22, 2025. Claim 70% Off TipRanks This Holiday Season Unlock hedge-fund level data and power...

Nasdaq 2d
First Week of MRUS February 2026 Options Trading

Investors in Merus NV (Symbol: MRUS) saw new options begin trading this week, for the February 2026 expiration. At Stock Options Channel , our YieldBoost formul...

First Week of MRUS February 2026 Options Trading

Analyst ratings

88%

of 16 ratings
Buy
12.5%
Hold
87.5%
Sell
0%

People also own

Based on the portfolios of people who own MRUS. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.